Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Identification and characterization of vasoactive intestinal peptide receptor antagonists with high-affinity and potent anti-leukemia activity.
Journal: bioRxiv : the preprint server for biology
Published: November 28, 2024
Targeting the VIP-VPAC Pathway in Melanoma Models Inhibits Tumor Growth and Liver Metastasis.
Journal: Cancer letters
Published: October 29, 2024
Identification and characterization of vasoactive intestinal peptide receptor antagonists with high-affinity and potent anti-leukemia activity.
Journal: The Journal of biological chemistry
Published: October 28, 2024
Plasma Cytokine and Chemokine Profiles Predict Efficacy and Toxicity of Anti-CD19 CAR-T Cell Therapy in Large B-Cell Lymphoma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: October 24, 2024
Chemical Modifications to Enhance the Drug Properties of a VIP Receptor Antagonist (ANT) Peptide.
Journal: International journal of molecular sciences
Published: March 21, 2024
VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic Cancer.
Journal: Cancer research
Published: November 17, 2023
The magic of small-molecule drugs during ex vivo expansion in adoptive cell therapy.
Journal: Frontiers in immunology
Published: January 30, 2023
Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma.
Journal: Nature communications
Published: August 19, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026